Stanford Type B Aortic Dissection in a Patient With Osteogenesis Imperfecta: A Case Report

Harsh Patel1

  • 1Department of Vascular Surgery, Royal Melbourne Hospital, Parkville, VIC, Australia.

Insights

Osteogenesis imperfecta patients rarely experience aortic dissection. This case highlights successful conservative management of Stanford Type B aortic dissection with beta-blockers and close surveillance, emphasizing individualized care for connective tissue disorders.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Connective Tissue Diseases

Background:

  • Osteogenesis imperfecta (OI) is a rare genetic disorder affecting type-1 collagen production.
  • Cardiovascular issues like aortic regurgitation are common in OI, but aortic dissection is exceptionally rare.
  • Managing vascular complications in OI is challenging due to tissue fragility.

Purpose of the Study:

  • To report a rare case of Stanford Type B aortic dissection in a patient with osteogenesis imperfecta.
  • To discuss the management and outcomes of this rare presentation.
  • To emphasize the need for individualized treatment strategies in OI patients with vascular pathology.

Main Methods:

  • A case report of a 69-year-old female with genetically confirmed osteogenesis imperfecta.
  • Diagnosis of acute, uncomplicated Stanford Type B aortic dissection via imaging.
  • Management with beta-blocker therapy and close imaging surveillance.

Main Results:

  • The patient's aortic dissection remained stable under medical management.
  • She remained asymptomatic at 6-month follow-up.
  • A reactive pleural effusion resolved without intervention.

Conclusions:

  • Conservative management with beta-blockers can be effective for Type B aortic dissection in OI patients.
  • Individualized management and intensive surveillance are crucial for OI patients with vascular complications.
  • Awareness of connective tissue fragility is vital for surgical and long-term care planning.